This initial generic network was extended to include prostate cancer-specific genes (e.g. SPOP, AR, etc.), pathways identified using ROMA (Martignetti et al., 2016), OmniPath (Türei et al., 2021), and up-to-date literature. This evidence concerns the gene SPOP and Familial prostate cancer.